Compare Hims and Hers Health Inc (HIMS) vs Palantir Technologies Inc (PLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Palantir Technologies Inc — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Palantir Technologies Inc trades at $209.05 (market cap $477.68B). The key difference: Palantir Technologies Inc is far larger — about 72.9× Hims and Hers Health Inc's market cap, and Palantir Technologies Inc is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Palantir Technologies Inc for 78 Days on average.
| HIMS | PLTR | |
|---|---|---|
Market Cap | $6.55B | $477.68B |
Volume | 14,842,814 | 41,744,992 |
Sector | Health | Technology |
52-Week High | $62.76 | $209.05 |
52-Week Low | $14.52 | $107.27 |
Typical Hold Time | 21 Days | 78 Days |
Enterprise Value | $7.25B | $468.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Palantir (PLTR) trades at $198.78, up 2.44% today, showing strong momentum with nine consecutive earnings beats. The stock exhibits bullish technical signals with current price near pivot point resistance at $199. Fundamentally, revenue grew 56.2% to $4.48B in 2025 with net income margin expanding to 36.3%, though valuation metrics remain elevated with P/E of 169.9 and P/S of 83.02. Recent partnership with Armada for sovereign AI infrastructure highlights ongoing business development.
Outlook remains positive given accelerating AI adoption and strong execution, but premium valuation and technical overbought conditions warrant caution. Key risks include growth normalization and competitive pressures. Analyst consensus is bullish with 54% buy ratings and $191.69 price target, though current price exceeds consensus target.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Palantir Technologies Inc
Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.
Read more on PLTR →
